Oppenheimer & Co. Inc. Boosts Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)
Oppenheimer & Co. Inc. grew its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 39.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,246 shares of the biotechnology company’s stock after buying an additional 6,246 shares during […]
Oppenheimer & Co. Inc. grew its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 39.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,246 shares of the biotechnology company’s stock after buying an additional 6,246 shares during […]
